<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): September 23, 1998
------------------------------
NORLAND MEDICAL SYSTEMS, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-26206 06-1387931
- --------------------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
106 Corporate Park Drive, Suite 106, White Plains, NY 10604
- --------------------------------------------------------------------------------
(Address of principal executive offices (Zip Code)
Registrant's telephone number, including area code: (914) 694-2285
----------------------------
ITEM 5. Other Events
On September 23, 1998, the Registrant was informed by Nasdaq that the
Registrant's Common Stock was delisted from The Nasdaq Stock Market effective
with the close of business September 23, 1998. On September 24, 1998, the
Registrant issued a press release with respect to such delisting. A copy of
the press release is attached hereto as Exhibit 99.1 and is incorporated
herein.
ITEM 7. Financial Statements and Exhibits
Exhibit 99.1. Press release dated September 24, 1998.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
NORLAND MEDICAL SYSTEMS, INC.
Date: September 24, 1998 By: /s/ Kurt W. Streams
-----------------------------------------
Kurt W. Streams
Vice President, Finance and Secretary
<PAGE>
EXHIBIT 99.1
Company Contact: Investor Relations Contact:
NORLAND MEDICAL SYSTEMS, INC. LIPPERT/HEILSHORN & ASSOCIATES
Kurt Streams Bruce Voss 310-575-4848
Vice President, Finance Kim Golodetz 212-838-3777
914-694-2285
NORLAND MEDICAL SYSTEMS, INC. ANNOUNCES NASDAQ DELISTING
WHITE PLAINS, NY, SEPTEMBER 24, 1998 -- NORLAND MEDICAL SYSTEMS, INC. today
announced that it received notification from The Nasdaq Stock Market, Inc. that
the Company's common stock was delisted from The Nasdaq Stock Market effective
with the close of business September 23, 1998. The Company's shares previously
traded on the Nasdaq National Market under the symbol NRLD.
Norland Medical Systems, Inc. develops, manufactures, sells and services a wide
range of bone densitometers used to assess bone mineral content and density, one
of several factors used by physicians to aid in the diagnosis and monitoring of
bone disorders, particularly osteoporosis. Osteoporosis is a disease that
affects more than 25 million Americans, 80% of whom are women. Driven by the
availability of new treatments for bone-related disorders, Norland is focusing
on bringing affordable, state-of-the-art diagnostic technology directly into the
physician's office in order to address a number of women's healthcare problems.
The Company also has rights to distribute medical diagnostic products developed
by Stratec Medizintechnik GmbH and IMRO Medical Systems.
